Michael J. Kramer

Michael J. Kramer

  • • 20 years of investing and industry experience
  • • 10 years as a buy side equity trader
  • • Founder of Mott Capital Management in 2014


Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.


Michael received his Master's Degree in Investment Management from Pace University.

Quote from Michael

"I like to help people become smarter and better investors."

Investopedia and Dotdash

Investopedia helps you understand complex financial concepts, learn and improve your investing skills, and learn how to manage your money. Whether you’re in a classroom, a boardroom or your living room, our editors and network of financial advisors and experts have answered your questions and proudly earned your trust since 1999. Investopedia is part of Dotdash, a collection of some of the web’s largest and most trusted digital media brands.

  1. Stocks

    Barclays is Positive on Ford and Fiat (F, FCAU)

    Barclays ups Ford and Fiat's ratings and price targets.
  2. Stocks

    Preview of NVDA Quarterly Earnings (NVDA, AVGO)

    A deep dive into the fundamentals of NDVA ahead of its Q4 earnings next week suggests that the shares are very expensive.
  3. Markets & Economy

    Strong January Jobs Report, But Wage Growth Still Soft

    Non-farm payrolls came in at 227k versus expectations of 175k, unemployment rose slightly to 4.8%.
  4. Stocks

    Pfizer Reportedly Considering Sale of Portfolio (PFE)

    The company reportedly wants to streamline its portfolio and potentially seek out other acquisition targets.
  5. Stocks

    CBS Radio to Merge with Entercom (ETM, CBS)

    Entercom shares are up on radio merger announcement.
  6. Stocks

    Allergan Shares Break Out, Surge Higher (AGN)

    Allergan shares have climbed 9% since Tuesday morning. Is this a Trump surge?
  7. Stocks

    Deep Dive into Sirius XM's Q4 Results (SIRI)

    Sirius XM depends on ARPU growth, and the firm's Q4 numbers and 2017 guidance suggest the company will have a good year for ...
  8. Buzz & Trending

    The Rise of Super Bowl Ticket Markets

    Buying a ticket for the Super Bowl is not easy, but technology is helping to make it easier.
  9. Markets & Economy

    FOMC Leave Rates Unchanged

    The FOMC left rates unchanged at its latest meeting, sees "improved" sentiment.
  10. Stocks

    Autos Deliver Unimpressive January Sales (GM,F)

    GM, Ford, and Fiat Chrysler see a slow start to 2017.
  11. Stocks

    The Contrarian: A Closer Look at LLY Earnings

    BMO and Barclay's raised PTs after Eli Lilly's quarterly and FY revenue beats, but there are questions about the report.
  12. Stocks

    Another Analyst Goes Negative on Movie Theaters (RGC, AMC)

    Credit Suisse has downgraded RGC and IMAX, while upping AMC's price target slightly.
  13. Stocks

    Pfizer Delivered Q4 and FY Mixed Results (PFE)

    PFE reported results for the fourth quarter and full year 2016 that are mixed. The stock is trading up.
  14. Stocks

    Eli Lilly & Co. Up on Revenue Beat (LLY)

    Shares of Eli Lilly & Co. are trading higher. Could it be quarterly numbers or comments from President Trump?
  15. Stocks

    Trump Meets Pharma CEOs, Stocks Pop (PFE, LLY)

    President Trump met with Pharma CEOs today at the White House and told them about his plans to streamline regulations.